Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by georgesoreloseon Jun 06, 2017 12:08pm
87 Views
Post# 26330055

RE:More pressure to "produce" ??

RE:More pressure to "produce" ??cut and paster is "brokeneded"...

KEY words tho...CONGRATS to CTSO et al !!!!!!!!!!!!!!!!!!!!!!!!!!!!

"We are delighted to be engaged with CytoSorbents to help create a comprehensive and impactful investor relations program," said Michael Rice, founder of LifeSci Partners. "The company has been successful in getting its CytoSorb blood purification technology onto the market in Europe, sales are on a positive growth trajectory, and there is a clear path to FDA approval in the U.S.  As with all LifeSci Partners clients, we see this relationship as a partnership, and we look forward to collaborating with Dr. Phillip Chan and his team to raise the company's profile and attract new institutional and retail investors."
Bullboard Posts